Prevalence of Trypanosoma evansi infection and associated risk factors in camels in eastern Chad

The prevalence of selected vector-borne diseases in dromedary camels (Camelus dromedarius) in the United Arab Emirates

Vector-borne diseases (VBDs) affecting dromedary camels (Camelus dromedarius) have considerable importance in the United Arab Emirates (UAE) because of the consequences associated with production decline and economic losses. Our study aimed to determine the prevalence of selected VBDs in camels in the UAE and identify risk factors. This research is currently affected by the low number of epidemiological molecular surveys addressing this issue. Blood samples were obtained from 425 dromedary camels from different locations across the UAE. Whole genomic DNA was isolated, and PCR screening was done to detect piroplasmids (Babesia/Theileria spp.), Trypanosoma spp., and Anaplasmataceae spp. (Anaplasma, Ehrlichia, Neorickettsia and Wolbachia spp.). Amplicons were sequenced, and phylogenetic trees were constructed. Trypanosoma sequences were identified as T. brucei evansi, whereas Anaplasmataceae sequences were identified as A. platys-like. All camels were negative for Babesia/Theileria spp. (0%); however, 18 camels were positive for T. b. evansi (4%) and 52 were positive for A. platys-like (12%). Mixed infection with T. b. evansi and A. platys-like was found in one camel. Statistical analyses revealed that camels with a brown coat colour were significantly more prone to acquire the A. platys-like strain compared with those having a clearer coat. A similar finding was observed when comparing urban moving camels with desert indoor and urban indoor camels. Continuous disease surveillance is required to ensure and maintain the good health status of the camels in the UAE. Nonetheless, the risk of disease outbreak remains if the misuse of drugs continues.

Biting Flies and Associated Pathogens in Camels in Amibara District of Afar Region, Ethiopia

Biting flies and associated pathogens are the major health constraints on camel production and productivity and are implicated in causing significant economic losses in the pastoralist community in Ethiopia. A cross-sectional study was conducted to estimate the prevalence of biting flies and their associated pathogens in relation to different risk factors in camels in the Amibara district, from October 2019 to April 2020. A total of 480 camels were examined for biting flies and associated pathogens. The study revealed that overall, 87% (418/480) and 18% (87/480) of camels were infested by one or more biting flies and infected with Trypanosoma evansi during the study period, respectively. The collected biting flies were identified into a total of 3 genera: Hippobosca, Stomoxys, and Tabanus under the stereomicroscope. In the present study, Hippobosca (40.4%) was the most prevalent biting fly, followed by Stomoxys (31%) and Tabanus (28.6%), which affected camels in the study area. Among camels infected with Trypanosoma evansi, 7.3% and 16% were positive for parasitological and serological tests, respectively. Age, body condition score, and season appeared to have a significant effect (p ≤ 0.005) on the prevalence of biting flies and T. evansi on dromedaries. According to the findings of this study, biting flies and Trypanosoma evansi were the most common limitations on camel health, production, and productivity in the study area. As a result of the possible threat of biting flies' infestation and Trypanosoma evansi on camels, all-around attention is required in terms of strategic acaricide application, proper antiprotozoal drug use, and raising knowledge about acaricide use to prevent and control biting flies' infestation.

Circulation of Trypanosoma evansi antibodies and risk variables among dromedary camels in Al Batinah governorates, Sultanate of Oman

Trypanosoma evansi is a blood protozoan infects camels with Surra disease and causes high economic losses. The current study was focused on estimating the seroprevalence and associated risk factors of Surra disease among camels, using 425 blood samples collected from 45 farms in nine Wilayats of Al Batinah governorates in the Sultanate of Oman. Host and environmental risk factors associated with T. evansi seroprevalence were analyzed by questionnaire arranged during sample collection. The overall seroprevalence by the serological CATT/T. evansi was 19.5% (83/425, CI: 16.0-23.6%). The seroconversion rate between the two governorates of north and south Al Batinah was not statistically significant (p > 0.05). However, the highest frequency was in Al Musannah at 41.7% (10/24, CI: 22.1-63.4%), and the lowest was in Al Khaburah at 10.5% (6/57, CI: 4.0-21.5%). Most of the owners in Al Khaburah (82.5%) were aware of T. evansi importance, and therefore they kept camels separate from ruminants. The ticks-free camels, racing camels and camels less than five years old showed higher T. evansi seroprevalence than other camels. The mean total protein was significantly (t = 2.817, p = 0.006) higher in seropositive camels (6.49 ± 0.75) compared to seronegative ones (6.25 ± 0.55), whereas PCV was not statistically different between the positive (28.96 ± 4.33) and negative camels (29.83 ± 3.63). Further studies are highly recommended to determine the prevalence and type of T. evansi in camels and ruminants in different governorates in Oman, especially in the Dhofar region, where the highest camel density is reported in the country.

Serological survey and associated risk factors' analysis of Trypanosomiasis in camels from Southern Tunisia

Surra (Trypanosoma evansi infection) is one of the main causes of dromedary (Camelus dromedarius) abortion, besides generating severe economic losses in herds. A sero-epidemiological survey was carried out between December 2018 and December 2019 in Southern Tunisia to estimate the seroprevalence of Trypanosoma evansi infection in camels and to determine its possible associated risk factors. Two-stage sampling was conducted to select breeders and camels targeted in our study. A total of 1205 blood samples were collected from 277 randomly selected farms belonging to six governorates of southern Tunisia. Sera were tested with the card agglutination test for Trypanosoma evansi (CATT/T. evansi) to detect the presence of anti-Trypanosoma. evansi antibodies. The overall individual and herd seroprevalence were 30.8% (95%CI 27.9–33.1%), 64.9% (95%CI 61.7–73), respectively. The seroprevalence of T. evansi infection both at the animal (26.2% (95%CI 21.4–30.9%) and herd level (84.4 (95%CI 76.3–92.5)) was higher in Kebili than in other governorates (P = 0.003). At the animal level, the infection rate with T. evansi was significantly associated to the age group among camels (P = 0.0008), production system (P = 0.006), bioclimatic stage (P = 0.02), and herd size (P = 0.04) in the univariable analysis. Multivariable logistic regression indicated that only age group and herd size were potential risk factors associated with Trypanosoma evansi infection. However, no significant variation of the seroprevalence of T. evansi with the sex of camels, farm type, and previous trypanocidal treatment were detected (P > 0.05). The findings of this study are crucial for this disease surveillance and control. Further investigations on the efficacy of the treatment against surra are needed to explain the persistence of the disease in the south of Tunisia.

Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria

Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique.

Seroprevalence and risk factors for Trypanosoma evansi, the causative agent of surra, in the dromedary camel (Camelus dromedarius) population in Southeastern Algeria

Surra, caused by Trypanosoma evansi, is a re-emerging animal trypanosomosis, which is of special concern for camel-rearing regions of Africa and Asia. Surra decreases milk yield, lessens animal body condition score and reduces market value of exported animals resulting in substantial economic losses. A cross-sectional seroprevalence study of dromedary camels was conducted in Algeria, and major risk factors associated with infection were identified by collecting data on animal characteristics and herd management practices. The seroprevalence of T. evansi infection was determined in sera of 865 camels from 82 herds located in eastern Algeria using an antibody test (card agglutination test for Trypanosomiasis – CATT/T. evansi). Individual and herd seroprevalence were 49.5% and 73.2%, respectively, indicating substantial exposure of camels to T. evansi in the four districts studied. Five significant risk factors for T. evansi hemoparasite infection were identified: geographical area, herd size, husbandry system, accessibility to natural water sources and type of watering. There was no association between breed, sex or age with T. evansi infection. Results of this study provide baseline information that will be useful for launching control programmes in the region and potentially elsewhere.

Assessment of Trypanosoma evansi prevalence and associated risk factors by immune trypanolysis test in camels from Ghardaïa district, southern Algeria

Trypanosoma evansi (T. evansi) is a flagellated parasite with worldwide distribution, mainly affecting camels, horses, dogs, buffaloes and wild animals. Trypanosomosis caused by T. evansi, known as surra, is a vector borne disease that affects the health and productivity of camels. The aim of our study was to assess the prevalence of trypanosomosis due to T. evansi in camels by the immune trypanolosis test and to identify associated risk factors. Our cross-sectional study was performed on 161 camels from Ghardaïa district, southern Algeria. A structured questionnaire was used to collect data on individual characteristics (age, gender and breed) husbandry management (herd size and activity of animals) and health conditions (history of abortion and clinical symptoms). The immune trypanolysis test revealed an overall seroprevalence of 9.3% (CI 95%, 5.9-14.9). Possible factors associated with T. evansi infection were analysed by univariate and multivariate logistic regression. The results showed that risk factors for camels were history of symptoms (P = 0.002, OR = 21.91, CI95% = 3.48-169.80), racing activities (P = 0.003, OR = 0.01, CI95% = 0.001-0.18) and small herd size (P = 0.013, OR = 8.22, CI95% = 1.64-49.75). In conclusion, this study showed that T. evansi is endemic in camels of Ghardaïa district. To reduce dissemination of the disease to non-endemic areas, it is recommended to minimise risk factors associated with the infection.

Investigation of Trypanosoma evansi infection in bullfighting cattle in Southern Thailand

Background and Aim

Trypanosoma evansi infection has been reported in Thai livestock such as beef and dairy cattle. However, there is little information on T. evansi infection in bullfighting cattle in Southern Thailand. The aim of this study was to investigate the infection of T. evansi in bullfighting cattle presented for health checks at the Animal Hospital, Faculty of Veterinary Science, Prince of Songkla University, Thailand.

Materials and Methods

Blood and serum samples were collected from 177 bullfighting cattle from April 2016 to February 2017 after bullfighting matches. Animal inspected showed signs of fever, weight loss, or exercise intolerance. Investigation of T. evansi infection was tested using polymerase chain reaction (PCR) with TBR primers and using indirect enzyme-linked immunosorbent assay with T. evansi crude antigen.

Results

The seroprevalence of T. evansi in bullfighting cattle was 22.60% (40/177). The PCR results detected no parasite DNA in this study. However, bullfighting cattle may serve as T. evansi reservoirs.

Conclusion

Health checking procedures for T. evansi should be promoted for bullfighting events so that infected animals can be quarantined in the preparatory stages of such events.

Prevalence and distribution of Trypanosoma evansi in camels in Somaliland

The prevalence and distribution of Trypanosoma evansi (T. evansi) infection on camels in Somaliland were studied using the card agglutination test (CATT/T. evansi). A total of 2575 camels were surveyed. The overall animal-level apparent (test) prevalence in Somaliland was 26.4%. The prevalence was highest in the Sahil Region (37.3%) followed by Togdheer (28.4%), Sanaag (27.4%), and Sool (26.2%). There was a significant difference in the seroprevalence between the regions (χ² = 35.2, df = 1, P < 0.001) with the prevalence being significantly higher in Sahil than in Woqooyi Galbeed and Awdal, respectively. Camels from the eastern districts were two times more likely to be infected than camels from the western districts (P < 0.001). Herds in the coastal area were also more likely to be infected (37.0%) than herds from the inland areas (26.9%).The seroprevalence varied significantly between body condition score groups (P < 0.001) with the highest seroprevalence in camels of poor body condition (39.5%) and the lowest in camels of good body condition (18.4%) score. Animals in poor body condition were almost three times more likely to be positive than animals in good body condition (OR = 2.9; 95% CI 2.2, 3.8).

Systematic review and meta-analysis on the global distribution, host range, and prevalence of Trypanosoma evansi

BACKGROUND

Surra is an animal trypanosomosis, caused by infection with Trypanosoma evansi and leading to severe economic loss due to mortality and morbidity. Compared to tsetse-transmitted animal trypanosomoses, little attention is given to the epidemiology and control of surra. Understanding its epidemiology is a first step in local and global efforts to control the disease. We conducted a systematic review and meta-analysis of published studies on distribution, host ranges and prevalence of T. evansi infection.

METHODS

Four electronic databases were searched for publications on T. evansi that met our inclusion criteria for the systematic review. Subsets of publications were subjected to meta-analysis for the pooled prevalence of T. evansi in various hosts as determined by multiple detection methods.

RESULTS

A total of 272 references published between 1906-2017 were included. Trypanosoma evansi was reported from 48 countries; largely confined to Africa and Asia with publications on natural T. evansi infections from 77% (n = 48) of countries, contrasting with seven countries in South America, and four in Europe where T. evansi is not endemic but was imported with infected animals. Although surra is a notifiable disease, many countries do not report surra cases to OIE. Trypanosoma evansi was mainly reported from dromedary camels in Africa and the Middle East, water buffaloes, cattle, dogs and horses in East and Southeast Asia. In South America, the acute form of the disease was reported in horses and dogs. Surra was also reported in a wide range of wild animals. Some rare human cases occurred in India and Vietnam. Meta-analysis on a subset of 165 publications indicated pooled prevalence of T. evansi in domestic animals ranging from 14-31%, 6-28% and 2-9% using respectively antibody detection, molecular and parasitological tests, with camels as the most affected, followed by buffalo and cattle.

CONCLUSIONS

This study illustrates that T. evansi affects a wide range of domestic and wild animals in Africa, Asia and South America with highest prevalence observed in dromedary camels. For successful control of T. evansi, both locally and globally, the role of wild animals in the epidemiology of surra needs further investigation.

Trypanosoma evansi infection and major risk factors for Iranian one-humped camels (Camelus dromedarius)

Trypanosoma evansi is a cosmopolitan protozoan which affects camelids and may cause illness and economic losses. The present study was aimed to determine the prevalence and geographic distribution of T. evansi in Iranian one-humped camels of South East Iran. A total of 369 camels were randomly examined from three parts of southeastern Iran from March to September 2015. Blood samples were taken from jugular vein and examined by using thin blood smear and mercuric chloride test. Ninety-five out of 369 examined camels (25.75%) with clinical signs (15.8%, 58/369) were found to be infected with T. evansi. The prevalence was significantly higher in camels more than 4 years-old (23.3%) with clinical signs (8.8%) than the other ones. There was no significant difference between the prevalence and sex (6.23% male and 19.51% female). Trypanosoma evansi infection was geographically found in all investigated regions with the highest prevalence in North (17.61%). The results indicated that T. evansi infection was prevalent in Iranian one-humped camels which could be useful finding to lunch control programs in the region.

Prevalence of camel trypanosomosis (surra) and associated risk factors in Borena zone, southern Ethiopia

A study was made to determine the prevalence of camel trypanosomosis (surra) and its associated risk factors in Borena zone, southern Ethiopia during 2013-2014. A total of 2400 blood samples were collected and examined by the buffy coat and thin blood film laboratory methods, and data were analyzed using the SPSS statistical software. The overall prevalence of camel trypanosomosis in the area was found to be 2.33 %. Prevalence was significantly different among the surveyed districts (P = 0.000), the pastoral associations (F = 6.408, P = 0.000), altitudinal divisions (P = 0.000), age groups (P = 0.034), and between animals possessing packed cell volume (PCV) values greater than 25 % and less than 25 % (P = 0.000); whereas, prevalence of the disease was not statistically significantly different between the sexes (P = 0.311) and among the body condition score groups (P = 0.739). The PCV of trypanosome positive and trypanosome negative camels differ significantly (P = 0.001), and prevalence of trypanosomosis was seen to be negatively correlated with packed cell volume (r = -0.069, P = 0.000) revealing the effect of camel trypanosomosis on anemia state of parasitized animals. In conclusion, camel trypanosomosis is a serious and economically important disease hampering camel production and productivity in southern Ethiopia. Further studies involving more sensitive molecular techniques to reveal the precise magnitude of the disease and to identify the vector species of the parasite are recommended.

Prevalence of Trypanosoma evansi in camels using molecular and parasitological methods in the southeast of Iran, 2011

Surra is caused by infection with the protozoal parasite, Trypanosoma evansi. This parasite was transmitted mechanically by biting flies which is widespread in camels in the world. The aim of this study is to determine the prevalence of T. evansi in camels in Rafsanjan, Kerman province, southeast of Iran. In this study, 95 suspected camels were randomly selected in 2011. Blood samples were taken from deep blood vessels. Thin and thick blood smears were prepared in laboratory. Blood smears were stained by Giemsa and studied under a light microscope. The positive blood samples were also used for further molecular analysis. Data were analyzed using SPSS 17.0 software and P ≤ 0.05 was considered as statistical difference. A total of 95 camels were examined for infection with T.evansi using parasitological and molecular methods. The overall prevalence of infection was 2.1 %. It was found that the frequency of infection was significantly higher (P < 0.05) in age group >6 years old than the corresponding younger camels. However, there was no significant difference when the gender was considered. PCR technique confirmed the two infected cases were T. evansi. Results of the present study indicated that surra is present in Rafsanjan county, Kerman province in an infection rate of 2.1 % in camels. To our knowledge, this is the first study reported from this province. Further investigations are needed to focus on vectors and to evaluate the risk factors.

An annotated checklist of the horse flies (Diptera: Tabanidae) of the Sinai Peninsula Egypt with remarks on ecology and zoogeography

During a 20-year survey we routinely collected Tabanidae in the Sinai resulting in a checklist of 22 species. We recorded 2 species for the Levant (Tabanus mordax Austen, 1911 and Tabanus gratus Loew, 1858), 4 species for Egypt (Nemorius irritans (Ricardo, 1901), Chrysops flavipes Meigen, 1804, Haematopota coronata Austen, 1908 and Haematopota pallens Loew, 1871), 5 species for the Sinai (Atylotus farinosus (Szilády, 1915), Tabanus arenivagusAusten, 1920, Tabanus autumnalis Linnaeus, 1761, Haematopota minusculaAusten, 1920 and Dasyrhamphis nigritus Fabricius, 1794) for the first time and confirmed one doubtful record for the Sinai (Tabanus albifacies Loew, 1856). Furthermore we collected 10 more species that were previously known or could be presumed from the Sinai. The status of 4 species (Atylotus pallescens (Walker, 1871), Tabanus unifasciatus Loew, 1858, Tabanus politus (Walker, 1871) and Tabanus terminalis Walker, 1871) doubtfully recorded from the Sinai is discussed. For most of the 22 species, apart from zoogeographical notes, host and ecological observations are also given.

Induction of protective immune response in mice by a DNA vaccine encoding Trypanosoma evansi beta tubulin gene

Surra, caused by Trypanosoma evansi, is an economically important veterinary disease of the tropics. Lack of effective drugs or vaccines have made surra a severe economic burden particularly in Asia and sub-Saharan Africa. In this study, a naked DNA construct encoding full length T. evansi beta (β) tubulin gene was used to immunize mice, to elicit a T. evansi β tubulin protein specific humoral immune response, delineated by ELISA. The serum cytokine profile post immunization, as determined by flow cytometry bead based assay, showed a predominant T helper cell Type 1 (Th1) response with significant increase in levels of IFNγ and TNFα. Lethal challenge with T. evansi blood-form trypomastigotes post immunization generated a β tubulin specific recall response and a stronger Th1 type serum cytokine profile which correlated with an extended survival and better control of parasitemia in the immunized mice.

Efficacy study of novel diamidine compounds in a Trypanosoma evansi goat model

Three diamidines (DB 75, DB 867 and DB 1192) were selected and their ability to cure T. evansi experimentally infected goats was investigated. A toxicity assessment and pharmacokinetic analysis of these compounds were additionally carried out. Goats demonstrated no signs of acute toxicity, when treated with four doses of 1 mg/kg/day (total dose 4 mg/kg). Complete curative efficacy of experimentally infected goats was seen in the positive control group treated with diminazene at 5 mg/kg and in the DB 75 and DB 867 groups treated at 2.5 mg/kg. Drug treatment was administered once every second day for a total of seven days. Complete cure was also seen in the group of goats treated with DB 75 at 1.25 mg/kg. DB 1192 was incapable of curing goats at either four-times 2.5 mg/kg or 1.25 mg/kg. Pharmacokinetic analysis clearly demonstrated that the treatment failures of DB 1192 were due to sub-therapeutic compound levels in goat plasma, whilst compound levels for DB 75 and DB 867 remained well within the therapeutic window. In conclusion, two diamidine compounds (DB 75 and DB 867) presented comparable efficacy at lower doses than the standard drug diminazene and could be considered as potential clinical candidates against T. evansi infection.

High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis

The African trypanosome Trypanosoma brucei, which persists within the bloodstream of the mammalian host, has evolved potent mechanisms for immune evasion. Specifically, antigenic variation of the variant-specific surface glycoprotein (VSG) and a highly active endocytosis and recycling of the surface coat efficiently delay killing mediated by anti-VSG antibodies. Consequently, conventional VSG-specific intact immunoglobulins are non-trypanocidal in the absence of complement. In sharp contrast, monovalent antigen-binding fragments, including 15 kDa nanobodies (Nb) derived from camelid heavy-chain antibodies (HCAbs) recognizing variant-specific VSG epitopes, efficiently lyse trypanosomes both in vitro and in vivo. This Nb-mediated lysis is preceded by very rapid immobilisation of the parasites, massive enlargement of the flagellar pocket and major blockade of endocytosis. This is accompanied by severe metabolic perturbations reflected by reduced intracellular ATP-levels and loss of mitochondrial membrane potential, culminating in cell death. Modification of anti-VSG Nbs through site-directed mutagenesis and by reconstitution into HCAbs, combined with unveiling of trypanolytic activity from intact immunoglobulins by papain proteolysis, demonstrates that the trypanolytic activity of Nbs and Fabs requires low molecular weight, monovalency and high affinity. We propose that the generation of low molecular weight VSG-specific trypanolytic nanobodies that impede endocytosis offers a new opportunity for developing novel trypanosomiasis therapeutics. In addition, these data suggest that the antigen-binding domain of an anti-microbial antibody harbours biological functionality that is latent in the intact immunoglobulin and is revealed only upon release of the antigen-binding fragment.

Haemoparasites, such as African trypanosomes, have developed potent immune evasion mechanisms to avoid antibody-mediated elimination. Consequently, trypanosome surface antigen-specific immunoglobulins in the absence of complement are non-trypanocidal. In contrast, certain monovalent nanobodies (Nb), monomeric antigen-binding domains derived from camelid Heavy-Chain Antibodies (HCAb) and which have a much lower molecular weight (15 kDa) than classical antibodies (150 kDa), efficiently lyse trypanosomes both in vitro and in vivo. This is surprising as classically immunoglobulin effector functions are mediated via the Fc-domain, which is absent from the Nb. We demonstrate that the Nb-mediated trypanolysis depends on the low molecular weight, monovalency and high affinity and is associated with loss of motility, a major block to endocytosis, energy depletion and cell death. Overall, targeting the parasite surface with low molecular weight, high affinity Nbs is sufficient to exert a direct therapeutic action. Therefore, the exploitation of Nbs against African trypanosomiasis represents a novel therapeutic strategy. Furthermore, demonstration that a high affinity antigen-binding Nb or Fab fragment lacking an effector domain (i.e., Fc-domain or an attached toxin) can exert a direct biological function, suggests that intact antibodies likely harbour latent functionality which only become revealed upon removal of the Fc-domain.

Genetic variability of Trypanosoma evansi isolates detected by inter-simple sequence repeat anchored-PCR and microsatellite

Studies on genetic variability in Trypanosoma evansi have been limited by a lack of high-resolution techniques. In this study, we have investigated the use of inter-simple sequence repeats (ISSR) and microsatellites in revealing polymorphism among T. evansi isolates. Twelve ISSR primers and five microsatellite loci were used to generate polymorphic bands and alleles, respectively, to investigate the genetic variability among T. evansi isolates from Africa and Asia. Seven of the twelve ISSR primers showed variability between isolates with a total of 71 fragments of which 49(69%) were polymorphic. Microsatellite analysis revealed a total of 60 alleles. On average the ISSR markers revealed a higher genetic diversity (23%) than microsatellites (21.1%). The two techniques showed a strong agreement of r=0.95 for Dice and r=0.91 for Jaccard indices in estimating the genetic distances between isolates. The distance UPGMA tree revealed two major clusters of T. evansi which correlate with the minicircle classification of subtype A and B. The cophenetic correlation coefficient between Dice and Jaccard based matrices were r=0.79 for microsatellites and r=0.73 for ISSR indicating a strong agreement between dendrograms. The results suggest that both ISSR and microsatellites markers are useful in detecting genetic variability within T. evansi.

Trypanosoma evansi: Genetic variability detected using amplified restriction fragment length polymorphism (AFLP) and random amplified polymorphic DNA (RAPD) analysis of Kenyan isolates

We compared two methods to generate polymorphic markers to investigate the population genetics of Trypanosoma evansi; random amplified polymorphic DNA (RAPD) and amplified restriction fragment length polymorphism (AFLP) analyses. AFLP accessed many more polymorphisms than RAPD. Cluster analysis of the AFLP data showed that 12 T.evansi isolates were very similar ('type A') whereas 2 isolates differed substantially ('type B'). Type A isolates have been generally regarded as genetically identical but AFLP analysis was able to identify multiple differences between them and split the type A T. evansi isolates into two distinct clades.

A preliminary passive surveillance of clinical diseases of cart pulling camels in Faisalabad metropolis (Pakistan)

We identified clinical disorders of all 200 city-dwelling cart pulling male camels attending the Veterinary Teaching Hospital, University of Agriculture, Faisalabad, Pakistan during a 7-year period (1993-1999). Data were collected prospectively on a predesigned form and collated. Diagnoses of different diseases/disorders were based on clinical examination supplemented with relevant laboratory tests. A total of 463 entries of 34 different clinical diseases/disorders were recorded. Sarcoptic mange (35% of 200 camels) followed by anhidrosis (23%) and trypanosomosis (19%) were the three most frequently encountered disorders. The body system most often involved was the integument (31%) followed by gastrointestinal (21%), locomotory (12%), thermoregulatory (6%), blood (6%), urogenital (6%), lymphatic (3%), nervous (3%), respiratory (3%) and ocular (3%).

Epidemiology of Trypanosoma vivax infection in cattle in the tse-tse free area of Lake Chad

A study was conducted in Chad to estimate the prevalence and the incidence of Trypanosoma vivax infection in herds of cattle from the Lake Chad area. The risk factors associated with disease were also identified. A random sample of 933 cattle from 17 herds was initially selected (January 1999, cold dry season). Cattle were identified by ear-tags and sampled in the rainy season (July 1999) and the cold dry season (January 2000). Each animal sampled was treated with diminazene aceturate (3.5mg/kg). Samples were examined for the presence of T. vivax using an antibody (indirect ELISA) and a parasite detection test (buffy-coat technique, BCT). Standardized questionnaires with information about the host and management practices were collected and evaluated for their association with seroprevalence (model 1) and parasitological prevalence (model 2) as indicator of host susceptibility to T. vivax infection. Risk factors were selected using two approaches: ordinary logistic regression (OLR) and generalized estimating equations (GEE) to account for within-herd correlation. The apparent prevalence was 1.6% using BCT and 42.3% with indirect ELISA. The true prevalence in the sample was estimated to (2.0%-8.0%) with two assumptions of BCT sensitivity. Overall, 58.8% (BCT) and 100.0% (ELISA) of the herds had a least one-positive animal. In January-July 1999, apparent monthly incidence was calculated at 0.24% in comparison with 0.76% for August 1999-January 2000. The true monthly incidence was estimated at 0.36%-1.43% for the first period and at 0.94%-3.78% for the second period. Risk factors associated with seroprevalence were age, race, a great number of small ruminants in the herd, and latitude and longitude of pasture area in the rainy season. Risk factors associated with BCT prevalence were duration of seasonal migration and longitude of pasture area in the rainy season. In conclusion, T. vivax is present and widely disseminated in the cattle herds of tse-tse free area of Lake Chad. Farm-level factors, particularly seasonal migration, should be considered as the main risk factors for infection and to host susceptibility to the parasite.

Characterization of Trypanosoma evansi type B

A distinctive feature of Trypanosoma evansi is the possession of a kinetoplast that contains homogeneous DNA minicircles, but lacks DNA maxicircles. Two major sequence variants of the minicircle have been described and here we have sequenced the type B variant and designed a specific PCR test to distinguish it from type A. Further a test based on maxicircles to distinguish T. brucei brucei from T. evansi was designed and evaluated. Using the designed PCR tests, we detected three type B isolates from camel blood samples collected in northern Kenya, more than 20 years after the first isolation of type B. Comparison of minicircle sequences from all four type B isolates shows >96% identity within the group, and 50-60% identity to type A minicircles. Phylogenetic analysis based on minicircle sequences reveals two clusters, one comprising isolates of type A and one of type B, while random amplification of polymorphic DNA show slight polymorphic bands within type B. Most T. evansi isolates analysed were heterozygous at a repetitive coding locus (MORF2). All type B isolates had one genotype designated 3/5 based on the alleles present. Three camel isolates, which had homogenous type A minicircles, lacked the RoTat 1.2 gene, while another five isolates were T. b. brucei, based on the heterogeneity of their minicircles and presence of maxicircles as demonstrated by PCR amplification of the gene for cytochrome oxidase subunit 1. Our results confirm the existence of T. evansi type B isolates, T. b. brucei and existence of T. evansi type A without RoTat 1.2 gene in Kenyan isolates.